In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
MSK and Hartford leadership holding certificate
Announcement
MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
In the Lab
Prostate Cancer Organoids Provide New Tool for Evaluating Therapies

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.
Pictured: Johanna Joyce
In the Lab
Researchers Find Clues to How Breast Cancer Can Infiltrate the Brain

A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.
Lab mouse with cultured human pluripotent stem cells
In the Lab
A New Mouse? Genetically Pliable Stem Cells Could Advance Research on Many Diseases

Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.
An origami crane illustrates the importance of RNA folding for regulating gene translation. The bolded sequences on the crane’s wings indicate the portion that is critical for the manufacture of many cancer-causing proteins.
In the Lab
Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting <em>MYC</em>, a cancer-causing gene that has remained elusive until now.
Pictured: Gabriela Chiosis
Finding
Hsp90: A Very Promising Target for Cancer Therapy

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.
Memorial Sloan Kettering is transforming our understanding and treatment of cancer in a myriad of ways.
Feature
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
Allysia Matthews, with Citymeals-on-Wheels staff donating reusable ice packs
In the Community
Giving Supplies a Second Life, and Making an Environmental Impact in the Process

Memorial Sloan Kettering “green” committees focus on waste reduction and energy efficiency throughout the institution while donating useful supplies to New York–area nonprofits.
Survivors and family members at our Manhattan event signed their names on a wall and wrote messages to staff and other patients.
Event
Olympic Gold Medalist and Cancer Survivor Shannon Miller Addresses Memorial Sloan Kettering Celebration

Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.
Pictured: Gum ball machines
Decoder
What Is Tumor Heterogeneity?

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.